The Situation Today
Evolving market conditions and increasing global competition has forced pharma organizations to reconsider their operating models. The focus is on improving efficiencies and realizing better value from business operations. As part of enterprise transformation efforts, pharma organizations are exploring new avenues of growth like global expansion, mergers and acquisitions, and adding new lines of business. This has necessitated a re-look at how IT enables this transformation and on how IT can integrate and support transformational initiatives. In this scenario, some of the key challenges faced by organizations are managing, optimizing and matching IT budgets to match industry benchmarks while ensuring that their IT infrastructure supports transformation objectives.
HCL’s Enterprise Transformation Services (ETS)
HCL’s Enterprise Transformation Services (ETS) enables pharmaceutical organizations to develop a transformational roadmap and an execution plan. This roadmap covers the key facets of the transformation, namely, business processes, applications, data, and information technology infrastructure.
How are our services different?
Value-driven. HCL provides value by assisting customers in optimizing IT intensity (revenue to IT spend ratio) and building business efficiencies by aligning business strategy with IT strategy.
Commitment to results. Guaranteed benefits of transformation by leveraging HCL's capability to architect and manage the customer's IT stack.
Highly purposed and focused. ETS is a key focus area for HCL, driving value in customer engagements. ETS offers flexibility through a discrete and integrated set of service offerings
What You Can Expect
- Reduced IT intensity (IT spend to revenue ratio)
- Improved operational excellence
- Business goals enablement through IT alignment
- Improved customer engagement
For more information, write to us at: firstname.lastname@example.org